The accumulation of Tc-labeled probes targeting saturable systems of the body is hindered by the presence of a large excess of unlabeled ligands needed to ensure high radiochemical yields in a short reaction time. To address the issue, we recently reported a novel concept of a metal-coordination-mediated synthesis of a bivalent Tc-labeled probe from a monovalent ligand using d-penicillamine (Pen) as a chelating molecule and c(RGDfK) as a model targeting device. The Pen-conjugated c(RGDfK) via a hexanoate linkage (Pen-Hx-c(RGDfK)) provided a bivalent [Tc]Tc-[(Pen-Hx-c(RGDfK)) that possessed much higher integrin αβ binding affinity than Pen-Hx-c(RGDfK) and visualized a murine tumor without purification. However, high radioactivity levels were observed in the abdominal regions, which necessitated improved pharmacokinetics of the probes for practical applications. In this study, a pharmacokinetic (PK) modifier was introduced to manipulate the pharmacokinetics of the Tc-Pen-based bivalent probe. The Hx linkage in Pen-Hx-c(RGDfK) was replaced with acetyl-d-serine-d-serine-glycine (Ac-ssG) or hexanoyl-d-serine-d-serine-d-serine (Hx-sss) to prepare Pen-Ac-ssG-c(RGDfK) or Pen-Hx-sss-c(RGDfK). Pen-Ac-ssG-c(RGDfK) impaired the complexation ability of Pen-Hx-c(RGDfK), and a monovalent Tc-labeled compound was generated at low ligand concentration. However, Pen-Hx-sss-c(RGDfK) provided the objective bivalent Tc-labeled probe in high radiochemical yields at a concentration similar to that of Pen-Hx-c(RGDfK). [Tc]Tc-[Pen-Hx-sss-c(RGDfK)] also possessed stability and integrin αβ binding affinity similar to those of [Tc]Tc-[Pen-Hx-c(RGDfK)]. As a result, [Tc]Tc-[Pen-Hx-sss-c(RGDfK)] exhibited tumor and abdominal radioactivity levels similar to and significantly lower than those of [Tc]Tc-[Pen-Hx-c(RGDfK)]. These findings indicate the incorporation of a tripeptide PK modifier to Pen-Hx-c(RGDfK) preserved the complexation ability and improved the pharmacokinetics of the resulting Tc-labeled bivalent probe without impairing the targeting ability. Thus, the [Pen-Hx-(PK modifier)-(targeting device)] would constitute a basic formulation for preparing the Tc-Pen-based bivalent probes for imaging saturable targets of the body.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.molpharmaceut.0c00070 | DOI Listing |
ACS Pharmacol Transl Sci
October 2024
Department of Immunology, Genetics and Pathology, Uppsala University, Dag Hammarskjölds Väg 20, 751 85 Uppsala, Sweden.
Sci Rep
September 2021
Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Hydroxamamide (Ham) is a thiol-free chelating agent that forms technetium-99m (Tc)-complexes with a metal-to-ligand ratio of 1:2 under moderate reaction conditions. Therefore, Ham-based chelating agents will produce Tc-labeled compounds with a bivalent targeting scaffold. For their universal usage, we developed a novel Ham-based bifunctional chelating agent, "Ham-Mal", with a maleimide group that can easily conjugate with a thiol group, for to preparing Tc-labeled bivalent ligand probes.
View Article and Find Full Text PDFMol Pharm
May 2020
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
The accumulation of Tc-labeled probes targeting saturable systems of the body is hindered by the presence of a large excess of unlabeled ligands needed to ensure high radiochemical yields in a short reaction time. To address the issue, we recently reported a novel concept of a metal-coordination-mediated synthesis of a bivalent Tc-labeled probe from a monovalent ligand using d-penicillamine (Pen) as a chelating molecule and c(RGDfK) as a model targeting device. The Pen-conjugated c(RGDfK) via a hexanoate linkage (Pen-Hx-c(RGDfK)) provided a bivalent [Tc]Tc-[(Pen-Hx-c(RGDfK)) that possessed much higher integrin αβ binding affinity than Pen-Hx-c(RGDfK) and visualized a murine tumor without purification.
View Article and Find Full Text PDFBioconjug Chem
February 2018
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, 260-8675, Japan.
In the synthesis of technetium-99m (Tc) labeled target-specific ligands, the presence of a large excess of unlabeled ligands over Tc in the injectate hinders target accumulation of Tc-labeled ligands by competing for target molecules. To circumvent the problem, we recently developed a concept of the metal coordination-mediated multivalency, and proved the concept with a Tc-labeled trivalent compound [Tc(CO)(CN-RGD)]. In this study, D-penicillamine (Pen) was selected as a chelating molecule and a cyclic RGDfK peptide was conjugated to Pen via a hexanoic linkage (Pen-Ahx-c(RGDfK)).
View Article and Find Full Text PDFNucl Med Biol
August 2007
Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Unlabelled: It was previously shown that the (99m)Tc-labeled hydrazinonicotinamide (HYNIC)-conjugated LTB4 antagonist MB81 visualized infectious foci in rabbits adequately and within a few hours after injection. Here, the bivalent HYNIC-conjugated LTB4 antagonist MB67 (analog of MB81) was fluorinated with (18)F via hydrazone formation and tested in vivo.
Methods: MB67 was [(18)F]-fluorinated via reaction of the [(18)F]-fluorinated intermediate p-[(18)F]-fluorobenzaldehyde ([(18)F]FB) and the HYNIC moiety of MB67 via hydrazone formation.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!